Copies of Biological Medicines: Similar But Not the Same? Pekka Kurki Commentary Open access 30 January 2023 Pages: 123 - 126
RNA Targeting and Gene Editing Strategies for Transthyretin Amyloidosis Adam IoannouMarianna FontanaJulian D. Gillmore Review Article Open access 16 February 2023 Pages: 127 - 142
Current Progress and Challenges in the Study of Adjuvants for Oral Vaccines Bingming OuYing YangMinyu Zhang Review Article 06 January 2023 Pages: 143 - 180
Targeting the Inside of Cells with Biologicals: Toxin Routes in a Therapeutic Context Maximilian RuschigAndrea L. J. Marschall Review Article Open access 02 February 2023 Pages: 181 - 203
Comparative Safety Profiles of Oncology Biosimilars: A Systematic Review and Network Meta-analysis HyeJung NaSun-Hong KwonEui-Kyung Lee Systematic Review 02 February 2023 Pages: 205 - 218
Systematic Literature Review of Economic Evaluations of Treatment Alternatives in Chronic Lymphocytic Leukemia László LorenzoviciLászló SzilberhornMarcell Csanádi Systematic Review Open access 16 February 2023 Pages: 219 - 233
The Global Landscape of Manufacturers of Follow-on Biologics: An Overview of Five Major Biosimilar Markets and 15 Countries Kevin KleinMümün GencogluPieter Stolk Original Research Article Open access 06 December 2022 Pages: 235 - 245
Retention Rate and Safety of Biologic and Targeted Synthetic DMARDs in Patients with RA-Associated Interstitial Lung Disease: A KOBIO Registry Study Sun-Kyung LeeKichul ShinHyoun-Ah Kim Original Research Article 09 February 2023 Pages: 247 - 257
Efficacy and Safety of Denosumab Biosimilar QL1206 Versus Denosumab in Patients with Bone Metastases from Solid Tumors: A Randomized Phase III Trial Huiping LiYan HuangLi Zhang Original Research Article Open access 21 February 2023 Pages: 259 - 269
Consistency of Product Quality for SB5, an Adalimumab Biosimilar JongAh Joanne LeeNayoung LeeIlkoo Kim Original Research Article Open access 31 January 2023 Pages: 271 - 277
